Hong Fang Song
Direktor/Vorstandsmitglied bei CG ONCOLOGY, INC.
Vermögen: 22 Mio $ am 30.04.2024
Profil
Hong Fang Song is an Independent Director at CG Oncology, Inc. and a Director at Enable Injections, Inc. She previously worked as a Managing Director at Cowen, Inc. She holds a graduate degree from Claremont Graduate University and an undergraduate degree from Fudan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CG ONCOLOGY, INC.
0,92% | 25.03.2024 | 613 928 ( 0,92% ) | 22 Mio $ | 30.04.2024 |
Aktive Positionen von Hong Fang Song
| Unternehmen | Position | Beginn |
|---|---|---|
| CG ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 01.11.2015 |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Hong Fang Song
| Unternehmen | Position | Ende |
|---|---|---|
| COWEN INC. | Corporate Officer/Principal | - |
Ausbildung von Hong Fang Song
| Fudan University | Undergraduate Degree |
| Claremont Graduate University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Enable Injections, Inc.
Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Health Technology |
Cowen, Inc.
 Cowen, Inc. Investment Banks/BrokersFinance Cowen, Inc. engages in the provision of financial services. It operates through following the segments: Operating Company and Asset Company. The Operating Company segment consists of the Cowen Investment Management, Investment Banking, Markets, and Research divisions. The Asset Company segment consists of the firm’s private investments, private real estate investments, and other legacy investment strategies. The firm offers investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services, and actively managed alternative investment products. The company was founded in 1918 and is headquartered in New York, NY. | Finance |
